Impactos da glicação no risco cardiovascular em pacientes com diabetes mellitus tipo 2
Objective: To describe the relationship between advanced glycation and the development of cardiovascular diseases in patients with type 2 Diabetes Mellitus (T2DM), emphasizing pathophysiological mechanisms, biomarkers, assessment methods, and prevention and treatment strategies. Methods: This is an integrative literature review conducted using the MEDLINE/PubMed, LILACS, SciELO, Embase, and Scopus databases. Studies published preferably between 2020 and 2025 in Portuguese, English, or Spanish were included. Study selection was performed independently by two reviewers, followed by a descriptive analysis of the evidence. Results/Discussion: The evidence demonstrates that advanced glycation end products (AGEs) promote inflammation, oxidative stress, endothelial dysfunction, and vascular remodeling, primarily through activation of the AGE–RAGE axis, thereby contributing to atherosclerosis and increasing cardiovascular risk. Biomarkers such as Nε-carboxymethyl lysine (CML), methylglyoxal-derived hydroimidazolone-1 (MG-H1), soluble receptor for advanced glycation end products (sRAGE), the hemoglobin glycation index (HGI), and skin autofluorescence have shown potential for cardiovascular risk stratification. However, their clinical application remains limited by the lack of standardized assessment methods and the predominance of observational studies. Final considerations: Advanced glycation is an important mechanism associated with increased cardiovascular risk in patients with T2DM. However, prospective studies and standardized protocols are still needed to validate the clinical application of these biomarkers and to expand their use in the prevention and management of cardiovascular complications.
Authors
- Hermínio Maurício da Rocha Sobrinho (ORCID: https://orcid.org/0000-0002-7521-3700)
- Ana Letícia Teixeira Couto
- Marcos Pereira Machado
Institutions
- Pontifícia Universidade Católica de Goiás (BR)
Publication Details
- Journal
- Revista Eletrônica Acervo Saúde
- Published
- 2026-11-16
- DOI
- https://doi.org/10.25248/reas.e25421.2026
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00